Clinical Research Focus. 44th Edition NIH Scientists Advance Gene-Editing Approach for Late-Onset Tay-Sachs NIH researchers have successfully used gene-editing to boost enzyme activity and ease symptoms of late-onset Tay-Sachs in human cells and mice. This breakthrough could pave the way for future therapies targeting Tay-Sachs and other lysosomal storage disorders. Learn more Milestone Achieved: Cromos Pharma Earns ISO 9001:2015 Certification Read more
Blue glowing pill splitting with electric crack, symbolizing disruption in pharma – Cromos Clinical Intelligence Report 50th Edition.
From Tariff-Free to Targeted: How the EU–US Trade Deal Puts Pharma in the Crosshairs The July 2025 EU–US trade agreement brought relief to many industries by averting a 30% U.S. duty on European goods. But for pharmaceuticals, the deal marked the end of a long-standing safe harbor. A new ceiling of 15% tariffs on EU exports, including branded medicines, has upended decades of tariff-free transatlantic trade and thrust the Read more
Global Oncology Trials, Local Relevance: Why the FDA Just Raised the Bar The FDA’s recent Complete Response Letter to Genentech’s BLA for Columvi (glofitamab) + GemOx in second‑line diffuse large B-cell lymphoma (DLBCL) has sent a crystal-clear signal: global trial data must be demonstrably relevant to U.S. patients. What Went Wrong? The phase III STARGLO trial enrolled 274 patients across 62 sites in 13 countries, but only 9% Read more
Cromos Pharma achieves ISO 9001:2015 certification, showcasing excellence in clinical research quality management
MILESTONE ACHIEVED: Cromos Pharma Earns ISO 9001:2015 Certification When compliance becomes a competitive advantage We are proud to announce that Cromos Pharma has achieved ISO 9001:2015 certification from TMS International Certification Body — a testament to our unwavering commitment to operational excellence in clinical research. Why This Matters In clinical research, ICH GCP compliance is the baseline. ISO 9001:2015 takes us further — it proves we operate within a Read more

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us